- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2015
- Public Summary Document (PSD) March 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2015 PBAC Meeting - Word
Evolocumab – March 2015
Evolocumab; 140 mg/1 mL injection, 1 x 1 mL injection device; Repatha®
Last updated
6 January 2016